J9331 Injection sirolimus prot part 1 milligrams
Also known as: sirolimus, Rapamune
Injection of sirolimus protein-bound formulation, 1 milligram. Mammalian target of rapamycin inhibitor with enhanced delivery.
In Plain Language
immunosuppressive cancer drug; transplant rejection prevention
Clinical Context
Used for renal transplant recipients to prevent rejection. Also used in some cancer protocols for mTOR pathway inhibition.
RVU Information
CPT J9331 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9331?
CPT J9331 (Injection sirolimus prot part 1 milligrams) is a J Codes (Drugs) code. Injection of sirolimus protein-bound formulation, 1 milligram. Mammalian target of rapamycin inhibitor with enhanced delivery.
How is J9331 administered?
CPT J9331 is administered by a healthcare provider, typically via injection or infusion. Used for renal transplant recipients to prevent rejection. Also used in some cancer protocols for mTOR pathway inhibition. It is used by Transplant Surgery, Nephrology, Oncology.
When is CPT J9331 used?
Used for renal transplant recipients to prevent rejection. Also used in some cancer protocols for mTOR pathway inhibition.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.